We subsequently formulated a far more distinct probe, [18F]CFA, which was used in The present analyze To judge dCK activity in tumors when dealt with with a small molecule dCK inhibitor. This probe can also be being researched within a clinical trial at our institution To judge changes in dCK https://marcotmfxo.blogdanica.com/32280117/a-secret-weapon-for-2f-dck